Jan
15
NON-SMALL CELL LUNG CANCER (NSCLC)
Completed | Phase II | Lung Cancer | ≥18 years
Overview
This study evaluated the efficacy and safety of a targeted treatment strategy in patients with advanced or metastatic non-small cell lung cancer with appropriate biological characteristics following disease progression on prior therapy.
Study population (general)
Adult patients with advanced or metastatic non-small cell lung cancer.
Principal Investigator
MSc, MD Quách Thanh Dung
Contact
CTU – Email – Phone
